Apply Online Application Due: December 1, 2013

TPCB Faculty

David Scheinberg, MD, PhD

Memorial Sloan-Kettering Cancer Center

Education

MD, 1983, The Johns Hopkins University School of Medicine

PhD, 1983, The Johns Hopkins University School of Medicine

AB, 1977, Cornell University

Research Topics

  • Biotechnology
    • Protein engineering
    • Nanotechnology
    • Radiochemistry
  • Biological therapies

Therapeutic Areas

  • Cancer
  • Immunology

photoThe overall goals of the Scheinberg lab are to develop novel targeted immunotherapies based on effectors of the immune system and to understand their mechanisms of action as well as the mechanisms of resistance to them. This includes passive agents (antibodies, targeted nano-devices, and ligands) and active agents (vaccines). An important goal is to take these new therapies into human clinical trials for testing.

Read more about Prof. Scheinberg’s research on the Sloan-Kettering website

Apply Online!